Evolve Private Wealth LLC Makes New Investment in CME Group Inc. $CME

Evolve Private Wealth LLC purchased a new position in shares of CME Group Inc. (NASDAQ:CMEFree Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 4,208 shares of the financial services provider’s stock, valued at approximately $929,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Whipplewood Advisors LLC raised its position in shares of CME Group by 2,075.0% during the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 83 shares during the period. Elkhorn Partners Limited Partnership acquired a new position in shares of CME Group in the 4th quarter valued at approximately $27,000. Hilton Head Capital Partners LLC bought a new stake in CME Group during the 4th quarter worth approximately $28,000. Legacy Wealth Managment LLC ID increased its stake in CME Group by 191.9% during the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 71 shares in the last quarter. Finally, Main Street Group LTD acquired a new stake in CME Group during the 1st quarter worth approximately $32,000. 87.75% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director William R. Shepard purchased 325 shares of CME Group stock in a transaction that occurred on Thursday, June 25th. The stock was acquired at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the purchase, the director directly owned 260,442 shares of the company’s stock, valued at $60,050,111.94. This trade represents a 0.12% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 0.30% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

CME has been the subject of several research analyst reports. The Goldman Sachs Group reduced their price target on shares of CME Group from $267.00 to $245.00 and set a “sell” rating for the company in a report on Tuesday, June 30th. TD Cowen cut their price objective on shares of CME Group from $323.00 to $273.00 and set a “buy” rating on the stock in a research report on Monday, June 22nd. Erste Group Bank cut CME Group from a “buy” rating to a “hold” rating in a report on Friday, June 5th. Deutsche Bank Aktiengesellschaft lowered CME Group from a “buy” rating to a “hold” rating and cut their price target for the company from $286.00 to $270.00 in a report on Wednesday. Finally, Barclays dropped their target price on CME Group from $316.00 to $270.00 and set an “equal weight” rating on the stock in a research report on Thursday, July 9th. Nine investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $288.56.

View Our Latest Research Report on CME Group

CME Group Price Performance

Shares of CME stock opened at $274.98 on Monday. The firm’s fifty day moving average price is $251.17 and its two-hundred day moving average price is $279.57. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 1 year low of $218.31 and a 1 year high of $329.16. The firm has a market capitalization of $98.88 billion, a P/E ratio of 23.32, a PEG ratio of 3.27 and a beta of 0.23.

CME Group (NASDAQ:CMEGet Free Report) last posted its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. The company had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The company’s quarterly revenue was up .8% on a year-over-year basis. During the same period in the prior year, the business posted $2.96 EPS. On average, equities analysts predict that CME Group Inc. will post 12.27 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be given a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 44.11%.

CME Group Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.